Latest filing published 12 Mar 2025 for Elicera Therapeutics AB (publ), €4,555.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Agneta Edberg: trading record in brief
Filings by Agneta Edberg span 2 companies, the busiest being Elicera Therapeutics AB and Elicera Therapeutics AB (publ). Over a trading history stretching from 10 June 2021 to 11 March 2025, the count stands at 4 filings.
Purchases make up the whole of the open-market record (1 purchase, €5,421). A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 1 share grant.
Most recently, on 12 March 2025, the filings show a transaction worth €4,555 in Elicera Therapeutics AB (publ). The most recent open-market purchase was published on 6 July 2021, 1,951 days ago. The median gap between a trade and its publication by Finansinspektionen is 1 day. For comparison, MAR article 19 gives managers three business days to notify a trade. This summary is built from Finansinspektionen disclosures alone and does not predict where the share price will go.
Companies and markets linked to Agneta Edberg
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 27,027 shares@ SEK 1.8543.3% of flowInterimsaktieISIN SE0015382080FI:csv-48e6e6fa0c5e6c11889f
- 4,518 shares@ SEK 16.2054.6% of flowBTU (betald tecknad unit)ISIN SE0021626306FI:csv-c9f2a36fb0638977e9d1
- 12,791 shares@ SEK 4.3045.4% of flowAktieISIN SE0015382080FI:csv-18d24e8e936233d72013Canonical exit: 3 Oct 2021 (T+90)
- 7,500 shares@ SEK 8.00100.0% of flowAktieISIN SE0015382080FI:csv-08ba017c5f6bfd3a5cd8
4 of 4 declarations